By co-transferring CD4+ T cells and B cells into tumor-bearing immunodeficient hosts, we determined the effects of B cell antigen presentation and antibody production on tumor protection and the anti-tumor CD4+ T cell response. The gene discussed is CD4; the disease is neoplasm.